End-stage renal disease

Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney disease

D. P. Martins, Souza, M. A., Baitello, M. E. Lopes, Nogueira, V., Oliveira, C. I. Ferreira, Pinhel, M. Ade Souza, Caldas, H. C., Filho, M. A., Souza, D. R. Silva, Martins, D. P., Souza, M. A., Baitello, M. E. Lopes, Nogueira, V., Oliveira, C. I. Ferreira, Pinhel, M. Ade Souza, Caldas, H. C., Filho, M. A., Souza, D. R. Silva, Martins, D. P., Souza, M. A., Baitello, M. E. Lopes, Nogueira, V., Oliveira, C. I. Ferreira, Pinhel, M. Ade Souza, Caldas, H. C., Filho, M. A., and Souza, D. R. Silva, Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney disease, vol. 15, p. -, 2016.

Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary nephropathy characterized by abnormal growth of epithelial cells. Genetic factors, including the vascular endothelial growth factor (VEGF) gene, play an important role in its progression. The main aim of this study was to evaluate the influence of VEGF-C936T polymorphism in the development and progression of ADPKD. In total, 302 individuals were studied and divided into two groups: G1 (73 patients with ADPKD) and G2 (229 individuals without the disease).

Subscribe to End-stage renal disease